Cargando…
Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis
Fibroblasts activation is a crucial process for development of fibrosis during idiopathic pulmonary fibrosis pathogenesis, and transforming growth factor (TGF)-β1 plays a key regulatory role in fibroblast activation. It has been reported that metformin (MET) alleviated bleomycin (BLM)-induced pulmon...
Autores principales: | Ji, Huimin, Dong, Hongliang, Lan, Yuejiao, Bi, Yuqian, Gu, Xuan, Han, Yongyue, Yang, Chongyang, Cheng, Minghan, Gao, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936158/ https://www.ncbi.nlm.nih.gov/pubmed/36817136 http://dx.doi.org/10.3389/fphar.2023.1089812 |
Ejemplares similares
-
Metformin attenuates diabetic renal injury via the AMPK-autophagy axis
por: Sun, Tingli, et al.
Publicado: (2021) -
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
por: Cheng, Demin, et al.
Publicado: (2021) -
Metabolic regulation by the intestinal metformin-AMPK axis
por: Zhang, Song-Yang, et al.
Publicado: (2022) -
Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis
por: Wen, Jia, et al.
Publicado: (2022) -
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling
por: Zhang, Lei, et al.
Publicado: (2015)